Ptosis-syndactyly-learning difficulties syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:238766
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Ptosis-syndactyly-learning difficulties syndrome is an extremely rare genetic condition that combines several features affecting different parts of the body. The name describes its three main characteristics: ptosis (drooping of the upper eyelids), syndactyly (webbing or fusion of fingers or toes), and learning difficulties (problems with intellectual development and academic skills). Children born with this syndrome may have droopy eyelids that can partially block their vision, fused or webbed digits on their hands or feet, and challenges with learning and cognitive development that become more apparent as they grow. Because this condition is so rare, very few cases have been described in the medical literature. The exact genetic cause is not yet fully understood, and there is no specific cure. Treatment focuses on managing each symptom individually. Surgery may be considered to correct the drooping eyelids and to separate fused fingers or toes, which can improve both function and appearance. Educational support and early intervention programs can help children with learning difficulties reach their full potential. A team of specialists is usually needed to address the various aspects of this syndrome, including eye doctors, hand surgeons, and developmental specialists. Families affected by this condition benefit from coordinated care and ongoing monitoring as the child grows.

Key symptoms:

Drooping of the upper eyelids (ptosis)Webbing or fusion of fingers or toesLearning difficultiesIntellectual disabilityDelayed developmental milestonesPossible vision problems due to droopy eyelidsReduced hand or foot function due to fused digitsPossible facial differencesSpeech and language delays

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Ptosis-syndactyly-learning difficulties syndrome.

View clinical trials →

No actively recruiting trials found for Ptosis-syndactyly-learning difficulties syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Ptosis-syndactyly-learning difficulties syndrome community →

No specialists are currently listed for Ptosis-syndactyly-learning difficulties syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Ptosis-syndactyly-learning difficulties syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Ptosis-syndactyly-learning difficulties syndromeForum →

No community posts yet. Be the first to share your experience with Ptosis-syndactyly-learning difficulties syndrome.

Start the conversation →

Latest news about Ptosis-syndactyly-learning difficulties syndrome

No recent news articles for Ptosis-syndactyly-learning difficulties syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is my child's ptosis, and does it need surgical correction to protect their vision?,What type of surgery is recommended for the syndactyly, and when is the best time to do it?,What early intervention services should we start right away?,Should we pursue genetic testing, and what might it tell us?,What is the expected learning trajectory, and what school supports should we request?,Are there any other health issues we should screen for as part of this syndrome?,How often should my child have follow-up appointments with each specialist?

Common questions about Ptosis-syndactyly-learning difficulties syndrome

What is Ptosis-syndactyly-learning difficulties syndrome?

Ptosis-syndactyly-learning difficulties syndrome is an extremely rare genetic condition that combines several features affecting different parts of the body. The name describes its three main characteristics: ptosis (drooping of the upper eyelids), syndactyly (webbing or fusion of fingers or toes), and learning difficulties (problems with intellectual development and academic skills). Children born with this syndrome may have droopy eyelids that can partially block their vision, fused or webbed digits on their hands or feet, and challenges with learning and cognitive development that become mo

At what age does Ptosis-syndactyly-learning difficulties syndrome typically begin?

Typical onset of Ptosis-syndactyly-learning difficulties syndrome is neonatal. Age of onset can vary across affected individuals.